These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33355258)

  • 1. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.
    Kanapka LG; Wadwa RP; Breton MD; Ruedy KJ; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer MJ; Jost E; Carria L; Emory E; Hsu LJ; Weinzimer SA; DeBoer MD; Buckingham BA; Oliveri M; Kollman C; Dokken BB; Cherñavvsky D; Beck RW;
    Diabetes Care; 2021 Feb; 44(2):473-478. PubMed ID: 33355258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial.
    Isganaitis E; Raghinaru D; Ambler-Osborn L; Pinsker JE; Buckingham BA; Wadwa RP; Ekhlaspour L; Kudva YC; Levy CJ; Forlenza GP; Beck RW; Kollman C; Lum JW; Brown SA; Laffel LM;
    Diabetes Technol Ther; 2021 May; 23(5):342-349. PubMed ID: 33216667
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial.
    O'Malley G; Messer LH; Levy CJ; Pinsker JE; Forlenza GP; Isganaitis E; Kudva YC; Ekhlaspour L; Raghinaru D; Lum J; Brown SA;
    Diabetes Technol Ther; 2021 Apr; 23(4):245-252. PubMed ID: 33155824
    [No Abstract]   [Full Text] [Related]  

  • 4. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control.
    Cobry EC; Kanapka LG; Cengiz E; Carria L; Ekhlaspour L; Buckingham BA; Hood KK; Hsu LJ; Messer LH; Schoelwer MJ; Emory E; Ruedy KJ; Beck RW; Wadwa RP; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Jun; 23(6):401-409. PubMed ID: 33404325
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.
    Schoelwer MJ; Kanapka LG; Wadwa RP; Breton MD; Ruedy KJ; Ekhlaspour L; Forlenza GP; Cobry EC; Messer LH; Cengiz E; Jost E; Carria L; Emory E; Hsu LJ; Weinzimer SA; Buckingham BA; Lal RA; Oliveri MC; Kollman CC; Dokken BB; Cherñavvsky DR; Beck RW; DeBoer MD;
    Diabetes Technol Ther; 2021 Jul; 23(7):475-481. PubMed ID: 33689454
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial.
    Kudva YC; Laffel LM; Brown SA; Raghinaru D; Pinsker JE; Ekhlaspour L; Levy CJ; Messer LH; Kovatchev BP; Lum JW; Beck RW; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Oct; 23(10):673-683. PubMed ID: 34115959
    [No Abstract]   [Full Text] [Related]  

  • 7. Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial.
    Kovatchev BP; Kollar L; Anderson SM; Barnett C; Breton MD; Carr K; Gildersleeve R; Oliveri MC; Wakeman CA; Brown SA
    Lancet Digit Health; 2020 Feb; 2(2):e64-e73. PubMed ID: 32864597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes.
    Collyns OJ; Meier RA; Betts ZL; Chan DSH; Frampton C; Frewen CM; Hewapathirana NM; Jones SD; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; Wheeler BJ; de Bock MI
    Diabetes Care; 2021 Apr; 44(4):969-975. PubMed ID: 33579715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a closed-loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: A prospective, multicentre, real-life study.
    Cherubini V; Rabbone I; Berioli MG; Giorda S; Lo Presti D; Maltoni G; Mameli C; Marigliano M; Marino M; Minuto N; Mozzillo E; Piccinno E; Predieri B; Ripoli C; Schiaffini R; Rigamonti A; Salzano G; Tinti D; Toni S; Zanfardino A; Scaramuzza AE; Gesuita R; ; Tiberi V; Savastio S; Pigniatiello C; Trada M; Zucchini S; Redaelli FC; Maffeis C; Bassi M; Rosanio FM; Delvecchio M; Buzzi P; Ricciardi MR; Carducci C; Bonfanti R; Lombardo F; Piccini B; Iafusco D; Calandretti M; Daga FA
    Diabetes Obes Metab; 2021 Nov; 23(11):2484-2491. PubMed ID: 34227214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.
    Anderson SM; Buckingham BA; Breton MD; Robic JL; Barnett CL; Wakeman CA; Oliveri MC; Brown SA; Ly TT; Clinton PK; Hsu LJ; Kingman RS; Norlander LM; Loebner SE; Reuschel-DiVirglio S; Kovatchev BP
    Diabetes Technol Ther; 2019 Jun; 21(6):356-363. PubMed ID: 31095423
    [No Abstract]   [Full Text] [Related]  

  • 12. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
    Brown SA; Breton MD; Anderson SM; Kollar L; Keith-Hynes P; Levy CJ; Lam DW; Levister C; Baysal N; Kudva YC; Basu A; Dadlani V; Hinshaw L; McCrady-Spitzer S; Bruttomesso D; Visentin R; Galasso S; Del Favero S; Leal Y; Boscari F; Avogaro A; Cobelli C; Kovatchev BP
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3674-3682. PubMed ID: 28666360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
    Nimri R; Muller I; Atlas E; Miller S; Fogel A; Bratina N; Kordonouri O; Battelino T; Danne T; Phillip M
    Diabetes Care; 2014 Nov; 37(11):3025-32. PubMed ID: 25078901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.
    Brown SA; Beck RW; Raghinaru D; Buckingham BA; Laffel LM; Wadwa RP; Kudva YC; Levy CJ; Pinsker JE; Dassau E; Doyle FJ; Ambler-Osborn L; Anderson SM; Church MM; Ekhlaspour L; Forlenza GP; Levister C; Simha V; Breton MD; Kollman C; Lum JW; Kovatchev BP;
    Diabetes Care; 2020 Aug; 43(8):1822-1828. PubMed ID: 32471910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.
    Kovatchev BP; Renard E; Cobelli C; Zisser HC; Keith-Hynes P; Anderson SM; Brown SA; Chernavvsky DR; Breton MD; Mize LB; Farret A; Place J; Bruttomesso D; Del Favero S; Boscari F; Galasso S; Avogaro A; Magni L; Di Palma F; Toffanin C; Messori M; Dassau E; Doyle FJ
    Diabetes Care; 2014 Jul; 37(7):1789-96. PubMed ID: 24929429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Controlled Trial of Mobile Closed-Loop Control.
    Kovatchev B; Anderson SM; Raghinaru D; Kudva YC; Laffel LM; Levy C; Pinsker JE; Wadwa RP; Buckingham B; Doyle FJ; Brown SA; Church MM; Dadlani V; Dassau E; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Lum J; Beck RW;
    Diabetes Care; 2020 Mar; 43(3):607-615. PubMed ID: 31937608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A; Gil-Poch E; Martín-Romo I; Arroyo-Díez FJ
    Diabetes Technol Ther; 2021 Sep; 23(9):609-615. PubMed ID: 33784187
    [No Abstract]   [Full Text] [Related]  

  • 18. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.